NLRP3 polymorphisms are associated with late-onset Alzheimer's disease in Han Chinese

Journal of Neuroimmunology

Volumn 265, Issue 1-2, 2013, Pages 91-95

  Tan, Meng Shan ^a   Yu, Jin Tai ^a,b,c   Jiang, Teng ^c   Zhu, Xi Chen ^c   Wang, Hui Fu ^c   Zhang, Wei ^b   Wang, Ying Li ^b   Jiang, Wei ^d   Tan, Lan ^a,b,c  

^a OCEAN UNIVERSITY OF CHINA   (China)

^b QINGDAO UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d Chinese Medical Association   (China)

Author keywords

Alzheimer's disease; Association study; NLRP3; Polymorphism; Susceptibility

Indexed keywords

CRYOPYRIN;

AGED; ALZHEIMER DISEASE; APOE EPSILON 4 GENE; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DNA FLANKING REGION; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NLRP3 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALZHEIMER'S DISEASE; ASSOCIATION STUDY; NLRP3; POLYMORPHISM; SUSCEPTIBILITY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; ASIAN CONTINENTAL ANCESTRY GROUP; CARRIER PROTEINS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84888362946     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.10.002     Document Type: Article

References (39)

1. Aksentijevich I., Putnam C.D., Remmers E.F., Mueller J.L., Le J., Kolodner R.D., Moak Z., Chuang M., Austin F., Goldbach-Mansky R., Hoffman H.M., Kastner D.L. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum. 2007, 56:1273-1285.
2. Ben Hamad M., Cornelis F., Marzouk S., Chabchoub G., Bahloul Z., Rebai A., Fakhfakh F., Ayadi H., Petit-Teixeira E., Maalej A. Association study of CARD8 (p.C10X) and NLRP3 (p.Q705K) variants with rheumatoid arthritis in French and Tunisian populations. Int. J. Immunogenet. 2012, 39:131-136.
3. Carlstrom M., Ekman A.K., Petersson S., Soderkvist P., Enerback C. Genetic support for the role of the NLRP3 inflammasome in psoriasis susceptibility. Exp. Dermatol. 2012, 21:932-937.
4. Crocker P.R., Paulson J.C., Varki A. Siglecs and their roles in the immune system. Nat. Rev. Immunol. 2007, 7:255-266.
5. Eikelenboom P., Veerhuis R., van Exel E., Hoozemans J.J., Rozemuller A.J., van Gool W.A. The early involvement of the innate immunity in the pathogenesis of late-onset Alzheimer's disease: neuropathological, epidemiological and genetic evidence. Curr. Alzheimer Res. 2011, 8:142-150.
6. Favis R., Day J.P., Gerry N.P., Phelan C., Narod S., Barany F. Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2. Nat. Biotechnol. 2000, 18:561-564.
7. Forabosco P., Ramasamy A., Trabzuni D., Walker R., Smith C., Bras J., Levine A.P., Hardy J., Pocock J.M., Guerreiro R., Weale M.E., Ryten M. Insights into TREM2 biology by network analysis of human brain gene expression data. Neurobiol. Aging 2013, 10.1016/j.neurobiolaging.2013.05.001.
8. Girardelli M., Maestri I., Rinaldi R.R., Tognon M., Boldorini R., Bovenzi M., Crovella S., Comar M. NLRP1 polymorphisms in patients with asbestos-associated mesothelioma. Infect. Agent Cancer 2012, 7:25.
9. Guerreiro R., Wojtas A., Bras J., Carrasquillo M., Rogaeva E., Majounie E., Cruchaga C., Sassi C., Kauwe J.S., Younkin S., Hazrati L., Collinge J., Pocock J., Lashley T., Williams J., Lambert J.C., Amouyel P., Goate A., Rademakers R., Morgan K., Powell J., St George-Hyslop P., Singleton A., Hardy J. TREM2 variants in Alzheimer's disease. N. Engl. J. Med. 2013, 368:117-127.
10. Halle A., Hornung V., Petzold G.C., Stewart C.R., Monks B.G., Reinheckel T., Fitzgerald K.A., Latz E., Moore K.J., Golenbock D.T. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 2008, 9:857-865.
11. Heneka M.T., Kummer M.P., Stutz A., Delekate A., Schwartz S., Vieira-Saecker A., Griep A., Axt D., Remus A., Tzeng T.C., Gelpi E., Halle A., Korte M., Latz E., Golenbock D.T. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 2013, 493:674-678.
12. Hitomi Y., Ebisawa M., Tomikawa M., Imai T., Komata T., Hirota T., Harada M., Sakashita M., Suzuki Y., Shimojo N., Kohno Y., Fujita K., Miyatake A., Doi S., Enomoto T., Taniguchi M., Higashi N., Nakamura Y., Tamari M. Associations of functional NLRP3 polymorphisms with susceptibility to food-induced anaphylaxis and aspirin-induced asthma. J. Allergy Clin. Immunol. 2009, 124(779-785):e776.
13. Hoffman H.M., Gregory S.G., Mueller J.L., Tresierras M., Broide D.H., Wanderer A.A., Kolodner R.D. Fine structure mapping of CIAS1: identification of an ancestral haplotype and a common FCAS mutation, L353P. Hum. Genet. 2003, 112:209-216.
14. Hollingworth P., Harold D., Sims R., Gerrish A., Lambert J.C., Carrasquillo M.M., Abraham R., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Jones N., Stretton A., Thomas C., Richards A., Ivanov D., Widdowson C., Chapman J., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Beaumont H., Warden D., Wilcock G., Love S., Kehoe P.G., Hooper N.M., Vardy E.R., Hardy J., Mead S., Fox N.C., Rossor M., Collinge J., Maier W., Jessen F., Ruther E., Schurmann B., Heun R., Kolsch H., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frolich L., Hampel H., Gallacher J., Hull M., Rujescu D., Giegling I., Goate A.M., Kauwe J.S., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Muhleisen T.W., Nothen M.M., Moebus S., Jockel K.H., Klopp N., Wichmann H.E., Pankratz V.S., Sando S.B., Aasly J.O., Barcikowska M., Wszolek Z.K., Dickson D.W., Graff-Radford N.R., Petersen R.C., van Duijn C.M., Breteler M.M., Ikram M.A., DeStefano A.L., Fitzpatrick A.L., Lopez O., Launer L.J., Seshadri S., Berr C., Campion D., Epelbaum J., Dartigues J.F., Tzourio C., Alperovitch A., Lathrop M., Feulner T.M., Friedrich P., Riehle C., Krawczak M., Schreiber S., Mayhaus M., Nicolhaus S., Wagenpfeil S., Steinberg S., Stefansson H., Stefansson K., Snaedal J., Bjornsson S., Jonsson P.V., Chouraki V., Genier-Boley B., Hiltunen M., Soininen H., Combarros O., Zelenika D., Delepine M., Bullido M.J., Pasquier F., Mateo I., Frank-Garcia A., Porcellini E., Hanon O., Coto E., Alvarez V., Bosco P., Siciliano G., Mancuso M., Panza F., Solfrizzi V., Nacmias B., Sorbi S., Bossu P., Piccardi P., Arosio B., Annoni G., Seripa D., Pilotto A., Scarpini E., Galimberti D., Brice A., Hannequin D., Licastro F., Jones L., Holmans P.A., Jonsson T., Riemenschneider M., Morgan K., Younkin S.G., Owen M.J., O'Donovan M., Amouyel P., Williams J. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat. Genet. 2011, 43:429-435.
15. Jonsson T., Atwal J.K., Steinberg S., Snaedal J., Jonsson P.V., Bjornsson S., Stefansson H., Sulem P., Gudbjartsson D., Maloney J., Hoyte K., Gustafson A., Liu Y., Lu Y., Bhangale T., Graham R.R., Huttenlocher J., Bjornsdottir G., Andreassen O.A., Jonsson E.G., Palotie A., Behrens T.W., Magnusson O.T., Kong A., Thorsteinsdottir U., Watts R.J., Stefansson K. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 2012, 488:96-99.
16. Jonsson T., Stefansson H., Steinberg S., Jonsdottir I., Jonsson P.V., Snaedal J., Bjornsson S., Huttenlocher J., Levey A.I., Lah J.J., Rujescu D., Hampel H., Giegling I., Andreassen O.A., Engedal K., Ulstein I., Djurovic S., Ibrahim-Verbaas C., Hofman A., Ikram M.A., van Duijn C.M., Thorsteinsdottir U., Kong A., Stefansson K. Variant of TREM2 associated with the risk of Alzheimer's disease. N. Engl. J. Med. 2013, 368:107-116.
17. Kastbom A., Verma D., Eriksson P., Skogh T., Wingren G., Soderkvist P. Genetic variation in proteins of the cryopyrin inflammasome influences susceptibility and severity of rheumatoid arthritis (the Swedish TIRA project). Rheumatology (Oxford) 2008, 47:415-417.
18. Kastbom A., Klingberg E., Verma D., Carlsten H., Forsblad-d'Elia H., Wesamaa J., Cedergren J., Eriksson P., Soderkvist P. Genetic variants in CARD8 but not in NLRP3 are associated with ankylosing spondylitis. Scand. J. Rheumatol 2013, 10.3109/03009742.2013.779020.
19. Lambert J.C., Grenier-Boley B., Chouraki V., Heath S., Zelenika D., Fievet N., Hannequin D., Pasquier F., Hanon O., Brice A., Epelbaum J., Berr C., Dartigues J.F., Tzourio C., Campion D., Lathrop M., Amouyel P. Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis. J. Alzheimers Dis. 2010, 20:1107-1118.
20. Lettre G., Lange C., Hirschhorn J.N. Genetic model testing and statistical power in population-based association studies of quantitative traits. Genet. Epidemiol. 2007, 31:358-362.
21. Martinon F. Orchestration of pathogen recognition by inflammasome diversity: variations on a common theme. Eur. J. Immunol. 2007, 37:3003-3006.
22. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
23. Menu P., Vince J.E. The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin. Exp. Immunol. 2011, 166:1-15.
24. Naj A.C., Jun G., Beecham G.W., Wang L.S., Vardarajan B.N., Buros J., Gallins P.J., Buxbaum J.D., Jarvik G.P., Crane P.K., Larson E.B., Bird T.D., Boeve B.F., Graff-Radford N.R., De Jager P.L., Evans D., Schneider J.A., Carrasquillo M.M., Ertekin-Taner N., Younkin S.G., Cruchaga C., Kauwe J.S., Nowotny P., Kramer P., Hardy J., Huentelman M.J., Myers A.J., Barmada M.M., Demirci F.Y., Baldwin C.T., Green R.C., Rogaeva E., St George-Hyslop P., Arnold S.E., Barber R., Beach T., Bigio E.H., Bowen J.D., Boxer A., Burke J.R., Cairns N.J., Carlson C.S., Carney R.M., Carroll S.L., Chui H.C., Clark D.G., Corneveaux J., Cotman C.W., Cummings J.L., DeCarli C., DeKosky S.T., Diaz-Arrastia R., Dick M., Dickson D.W., Ellis W.G., Faber K.M., Fallon K.B., Farlow M.R., Ferris S., Frosch M.P., Galasko D.R., Ganguli M., Gearing M., Geschwind D.H., Ghetti B., Gilbert J.R., Gilman S., Giordani B., Glass J.D., Growdon J.H., Hamilton R.L., Harrell L.E., Head E., Honig L.S., Hulette C.M., Hyman B.T., Jicha G.A., Jin L.W., Johnson N., Karlawish J., Karydas A., Kaye J.A., Kim R., Koo E.H., Kowall N.W., Lah J.J., Levey A.I., Lieberman A.P., Lopez O.L., Mack W.J., Marson D.C., Martiniuk F., Mash D.C., Masliah E., McCormick W.C., McCurry S.M., McDavid A.N., McKee A.C., Mesulam M., Miller B.L., Miller C.A., Miller J.W., Parisi J.E., Perl D.P., Peskind E., Petersen R.C., Poon W.W., Quinn J.F., Rajbhandary R.A., Raskind M., Reisberg B., Ringman J.M., Roberson E.D., Rosenberg R.N., Sano M., Schneider L.S., Seeley W., Shelanski M.L., Slifer M.A., Smith C.D., Sonnen J.A., Spina S., Stern R.A., Tanzi R.E., Trojanowski J.Q., Troncoso J.C., Van Deerlin V.M., Vinters H.V., Vonsattel J.P., Weintraub S., Welsh-Bohmer K.A., Williamson J., Woltjer R.L., Cantwell L.B., Dombroski B.A., Beekly D., Lunetta K.L., Martin E.R., Kamboh M.I., Saykin A.J., Reiman E.M., Bennett D.A., Morris J.C., Montine T.J., Goate A.M., Blacker D., Tsuang D.W., Hakonarson H., Kukull W.A., Foroud T.M., Haines J.L., Mayeux R., Pericak-Vance M.A., Farrer L.A., Schellenberg G.D. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet. 2011, 43:436-441.
25. Pontillo A., Brandao L., Guimaraes R., Segat L., Araujo J., Crovella S. Two SNPs in NLRP3 gene are involved in the predisposition to type-1 diabetes and celiac disease in a pediatric population from northeast Brazil. Autoimmunity 2010, 43:583-589.
26. Pontillo A., Vendramin A., Catamo E., Fabris A., Crovella S. The missense variation Q705K in CIAS1/NALP3/NLRP3 gene and an NLRP1 haplotype are associated with celiac disease. Am. J. Gastroenterol. 2011, 106:539-544.
27. Pontillo A., Catamo E., Arosio B., Mari D., Crovella S. NALP1/NLRP1 genetic variants are associated with Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2012, 26:277-281.
28. Pontillo A., Oshiro T.M., Girardelli M., Kamada A.J., Crovella S., Duarte A.J. Polymorphisms in inflammasome' genes and susceptibility to HIV-1 infection. J. Acquir. Immune Defic. Syndr. 2012, 59:121-125.
29. Querfurth H.W., LaFerla F.M. Alzheimer's disease. N. Engl. J. Med. 2010, 362:329-344.
30. Rubinsztein D.C., Easton D.F. Apolipoprotein E genetic variation and Alzheimer's disease. A meta-analysis. Dement. Geriatr. Cogn. Disord. 1999, 10:199-209.
31. Sastre M., Richardson J.C., Gentleman S.M., Brooks D.J. Inflammatory risk factors and pathologies associated with Alzheimer's disease. Curr. Alzheimer Res. 2011, 8:132-141.
32. Schoultz I., Verma D., Halfvarsson J., Torkvist L., Fredrikson M., Sjoqvist U., Lordal M., Tysk C., Lerm M., Soderkvist P., Soderholm J.D. Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohn's disease in Swedish men. Am. J. Gastroenterol. 2009, 104:1180-1188.
33. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
34. Tan M.S., Yu J.T., Jiang T., Zhu X.C., Tan L. The NLRP3 inflammasome in Alzheimer's disease. Mol. Neurobiol 2013, 10.1007/s12035-013-8475-x.
35. Verma D., Lerm M., Blomgran Julinder R., Eriksson P., Soderkvist P., Sarndahl E. Gene polymorphisms in the NALP3 inflammasome are associated with interleukin-1 production and severe inflammation: relation to common inflammatory diseases?. Arthritis Rheum. 2008, 58:888-894.
36. Villani A.C., Lemire M., Fortin G., Louis E., Silverberg M.S., Collette C., Baba N., Libioulle C., Belaiche J., Bitton A., Gaudet D., Cohen A., Langelier D., Fortin P.R., Wither J.E., Sarfati M., Rutgeerts P., Rioux J.D., Vermeire S., Hudson T.J., Franchimont D. Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat. Genet. 2009, 41:71-76.
37. Xiao Z., Xiao J., Jiang Y., Zhang S., Yu M., Zhao J., Wei D., Cao H. A novel method based on ligase detection reaction for low abundant YIDD mutants detection in hepatitis B virus. Hepatol. Res. 2006, 34:150-155.
38. Yang J., Benyamin B., McEvoy B.P., Gordon S., Henders A.K., Nyholt D.R., Madden P.A., Heath A.C., Martin N.G., Montgomery G.W., Goddard M.E., Visscher P.M. Common SNPs explain a large proportion of the heritability for human height. Nat. Genet. 2010, 42:565-569.
39. Zhang A.Q., Zeng L., Gu W., Zhang L.Y., Zhou J., Jiang D.P., Du D.Y., Hu P., Yang C., Yan J., Wang H.Y., Jiang J.X. Clinical relevance of single nucleotide polymorphisms within the entire NLRP3 gene in patients with major blunt trauma. Crit. Care 2011, 15:R280.